Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
71 /100
HIGH RISK
Score updated Aug 28, 2026

INAB — IN8bio, Inc. Dilution Risk Tracker

Track INAB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INAB — Get alerts when the score changes →

As of August 28, 2026, IN8bio, Inc. (INAB) has a DilutionWatch DilutionScore of 71/100, rated HIGH dilution risk. IN8bio, Inc. has a market capitalization of $18.41M, 9.86M shares outstanding, 20 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
65
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 26%
🔄 Reverse Split model est. 40%
• 50-day avg $1.54 approaching $1 threshold
• 9 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (71/100)
🔔 Track INAB — Get forecast alerts →

Market Data

Market Cap$18.41M
Shares Outstanding9.86M
Float7.03M
Cash$18.13M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 15.3% shares (2026Q1 vs prior)
20 institutional holders · 3.75M shares
#1 Alyeska Investment Group, L.P. 944.3K shares
#2 FRANKLIN RESOURCES INC 914.5K shares
#3 683 Capital Management, LLC 724.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest24.9K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual INAB Dilution Snapshot

IN8bio, Inc. (INAB) has a DilutionScore of 71/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track INAB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INAB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INAB
INAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.